Humana Reaffirms 2026 Earnings Guidance in Investor Meetings

robot
Abstract generation in progress

Humana (HUM) plans to reaffirm its 2026 financial outlook, including diluted EPS of at least $8.89 and adjusted EPS of at least $9.00, during upcoming investor meetings in March 2026. The company emphasizes adjusted EPS as a key performance metric, noting that GAAP EPS guidance may change due to strategic initiatives. Spark, TipRanks’ AI Analyst, rates HUM as Neutral, citing weakening profitability, deterioration in 2025 cash flow, and conservative 2026 guidance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments